Lanoxin and Cervical cord compression - a phase IV clinical study of FDA data

Summary:

Cervical cord compression is reported as a side effect among people who take Lanoxin (digoxin), especially for people who are 60+ old, also take Finasteride, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Cervical cord compression when taking Lanoxin. It is created by eHealthMe based on reports of 21,602 people who have side effects when taking Lanoxin from the FDA, and is updated regularly.

What is Lanoxin?

Lanoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 21,852 Lanoxin users. Check the latest studies of Lanoxin.

What is Cervical cord compression?

Cervical cord compression (compression of spinal cord at site of cervical vertebrae) is found to be associated with 173 drugs and 144 conditions by eHealthMe. Check the latest studies of Cervical cord compression.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

21,602 people reported to have side effects when taking Lanoxin.
Among them, 17 people (0.08%) have Cervical cord compression.

Could Lanoxin cause Cervical cord compression?

Among these 17 people:

What is the age of people who have Cervical cord compression when taking Lanoxin? *

What are other drugs people take besides Lanoxin? *

What are other side effects people have besides Cervical cord compression? *

Weakness: 17 people, 100.00%
Intestinal Obstruction: 17 people, 100.00%
Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back)): 17 people, 100.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 17 people, 100.00%
Ludwig Angina (a type of cellulitis that involves the floor of the mouth, under the tongue): 17 people, 100.00%
Vision Blurred: 17 people, 100.00%
Lung Infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung): 17 people, 100.00%
Chondromalacia (anterior knee pain due to irritation of the cartilage on the under surface of the kneecap): 17 people, 100.00%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 17 people, 100.00%
Mastication Disorder (disease of chewing food): 17 people, 100.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 17 people, 100.00%
Swelling: 1 person, 5.88%
Procedural Pain: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Lanoxin and have Cervical cord compression?

- Check whether Cervical cord compression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lanoxin:

Lanoxin (21,852 reports)

Browse all side effects of Lanoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cervical cord compression:

Cervical cord compression (173 drugs)

Browse all the conditions that are associated with Cervical cord compression:

Cervical cord compression (144 conditions)

Related publications that referenced our studies

Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .

How the study uses the data?

The study uses data from the FDA. It is based on digoxin (the active ingredients of Lanoxin) and Lanoxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.